NKCx Histopathological outcome* within 12 months after cervix cytology in 2024
131 Sörmland

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 34 10.7% 18 5.7% 14 4.4% . . . . 1 0.3% 250 78.9% 317 100.0%
ASCUS 102 30.4% 131 39.0% 57 17.0% 1 0.3% . . 7 2.1% 38 11.3% 336 100.0%
LSIL 77 24.8% 135 43.4% 66 21.2% . . 2 0.6% 1 0.3% 30 9.6% 311 100.0%
Atypical glandular cells/AGC . . 1 50.0% . . . . 1 50.0% . . . . 2 100.0%
Unclear atypia . . 1 100.0% . . . . . . . . . . 1 100.0%
ASC-H 9 19.1% 12 25.5% 23 48.9% 3 6.4% . . . . . . 47 100.0%
HSIL 2 4.8% 3 7.1% 33 78.6% 1 2.4% 1 2.4% 1 2.4% 1 2.4% 42 100.0%
Totalt 224 21.2% 301 28.5% 193 18.3% 5 0.5% 4 0.4% 10 0.9% 319 30.2% 1056 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403